• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Hepatol . Prognostic value of liver biochemical parameters for COVID-19 mortality

tetano

Editor, Senior Moderator
Ann Hepatol


. 2020 Nov 3;S1665-2681(20)30204-0.
doi: 10.1016/j.aohep.2020.10.007. Online ahead of print.
Prognostic value of liver biochemical parameters for COVID-19 mortality


Lin Ye[SUP] 1 [/SUP], Bin Chen[SUP] 2 [/SUP], Yitong Wang[SUP] 3 [/SUP], Yi Yang[SUP] 1 [/SUP], Jiling Zeng[SUP] 4 [/SUP], Guangtong Deng[SUP] 1 [/SUP], Yuhao Deng[SUP] 5 [/SUP], Furong Zeng[SUP] 6 [/SUP]



Affiliations

Abstract

Introduction: Coronavirus Disease 2019 (COVID-19) has brought great challenges to global public health. However, a comprehensive analysis of the relationship between liver biochemical parameters and COVID-19 mortality is quite limited.
Methods: We searched the following electronic databases: PubMed, Embase, Cochrane Library, Web of Science, Scopus, Wanfang and China National Knowledge Infrastructure database until May 5, 2020. STATA software was used for the statistical analyses.
Results: A total of 25 studies involving 5971 COVID-19 patients were included in our analysis. Compared with non-survivors, survivors had lower levels of aspartate aminotransferase (AST) (weighted mean difference [WMD]=-16.71U/L, 95%CI=[-21.03, -12.40], P<0.001), alanine transaminase (ALT) (WMD=-5.20U/L, 95%CI=[-8.00, -2.41], P<0.001), total bilirubin (TBIL) (WMD=4.40μmol/L, 95%CI=[-5.11, -3.70], P<0.001) and lactic dehydrogenase (LDH) (WMD=-252.44U/L, 95%CI=[-289.57, -215.30], P<0.001), and higher albumin (ALB) level (WMD=4.47g/L, 95%CI=[3.47, 5.47], P<0.001). Besides, survivors had lower proportions of these abnormally increased parameters (AST: OR=0.25, 95%CI=[0.15, 0.41], P<0.001; ALT: OR=0.49, 95%CI=[0.37, 0.64], P<0.001; TBIL: (OR=0.20, 95%CI=[0.12, 0.34], P<0.001; LDH, OR=0.09, 95%CI=[0.06, 0.14], P<0.001), and lower proportion of abnormally decreased ALB (OR=0.16, 95%CI=[0.07, 0.38], P<0.001). Meta-analysis based on standard mean difference and sensitivity analysis did not change the conclusions. Egger test did not detect the presence of publication bias.
Conclusions: Liver biochemical parameters were strongly correlated with COVID-19 mortality. Measurement of these liver biochemical parameters might assist clinicians to evaluate the prognosis of COVID-19.

Keywords: COVID-19; Liver biochemical parameters; Meta-analysis.; Mortality.
 
Back
Top Bottom